Table 3.

RBC and plasma physiological metrics in patients with TDT across transfusion

VariableBeforeAfterWeekP valueRBC unitsP value
Hemolysis rate 
Cell-free Hb, mg/dL 13.3 ± 11.4 16.4 ±14.5  11.7 ± 11.7  .008 72.6 ± 65.4  <.001 
Osmotic hemolysis, MCF, NaCl% 0.378 ± 0.048 0.385 ± 0.043 0.385 ± 0.042 .077 0.458 ± 0.025  <.001 
Osmotic hemolysis, 24 hours, MCF, NaCl% 0.419 ± 0.065 0.429 ± 0.057  0.434 ± 0.056  .061 0.493 ± 0.035  <.001 
Mechanical hemolysis, MFI, % 0.732 ± 0.182 0.802 ± 0.227  0.663 ± 0.161,  <.001 0.978 ± 0.273  <.001 
Oxidative hemolysis, mg/dL 7.4 ± 7.6 6.4 ± 6.0 8.4 ± 7.2 ns 11.2 ± 9.7  .010 
Oxidative stress 
ROS, RFU 652 ± 415 524 ± 186 686 ± 293  .023 546 ± 233 ns 
tBHP-induced ROS, RFU 3242 ± 1606 3085 ± 2339 4471 ± 3927 ns 2909 ± 2345  .082 
PHZ-induced ROS, RFU 7633 ± 1324 8149 ± 1699 8215 ± 2621 ns 8527 ± 1623  .013 
Membrane-bound hemichromes, μΜ 25.9 ± 6.4 26.8 ± 6.7 30.2 ± 7.7  .061 22.6 ± 5.3  .074 
PS+ RBCs, % 0.86 ± 1.12 0.79 ± 1.00 0.69 ± 0.93 ns 0.23 ± 0.15  <.001 
Proteolytic proteasome activity 
CH-like, RFU 29 161 ± 13 451 29 690 ± 12915 31 618 ± 17 068 ns 28 526 ± 13 289 ns 
CASP-like, RFU 19 162 ± 8051 18 874 ± 4868 19 272 ± 6850 ns 19 172 ± 5 936 ns 
TR-like, RFU 48 420 ± 17 168 52 596 ± 18410 53 394 ± 18 781 ns 44 305 ± 12 097 ns 
CH-like, m, RFU 26 209 ± 22 747 25 423 ± 15 046 36 494 ± 25 101,  .003 44 142 ± 30 656  .004 
CASP-like, m, RFU 21 222 ± 19 234 22 757 ± 18 233 29 478 ± 19 267,  .007 35 463 ± 27 523  .011 
TR-like, m, RFU 27 755 ± 28 048 26 053 ± 21 901 31 217 ± 25 752 ns 29 430 ± 20 838 ns 
Plasma sEVs 
sEV concentration, ×1010/mL 20.2 ± 8.4 20.4 ± 9.5 21.2 ± 9.6 ns 7.4 ± 3.3  .004 
sEV size, nm 159 ± 24 152 ± 25 151 ± 28 .093 110 ± 14  <.001 
Plasma antioxidant capacity 
TAC, μM Fe2+ 406 ± 91 407 ± 87 381 ± 86,  .024 248 ± 54  <.001 
UAiAC, μM Fe2+ 217 ± 73 210 ± 72 207 ± 66 ns 124 ± 47  <.001 
UAdAC, μM Fe2+ 190 ± 60 197 ± 54 174 ± 67  .018 124 ± 32  <.001 
VariableBeforeAfterWeekP valueRBC unitsP value
Hemolysis rate 
Cell-free Hb, mg/dL 13.3 ± 11.4 16.4 ±14.5  11.7 ± 11.7  .008 72.6 ± 65.4  <.001 
Osmotic hemolysis, MCF, NaCl% 0.378 ± 0.048 0.385 ± 0.043 0.385 ± 0.042 .077 0.458 ± 0.025  <.001 
Osmotic hemolysis, 24 hours, MCF, NaCl% 0.419 ± 0.065 0.429 ± 0.057  0.434 ± 0.056  .061 0.493 ± 0.035  <.001 
Mechanical hemolysis, MFI, % 0.732 ± 0.182 0.802 ± 0.227  0.663 ± 0.161,  <.001 0.978 ± 0.273  <.001 
Oxidative hemolysis, mg/dL 7.4 ± 7.6 6.4 ± 6.0 8.4 ± 7.2 ns 11.2 ± 9.7  .010 
Oxidative stress 
ROS, RFU 652 ± 415 524 ± 186 686 ± 293  .023 546 ± 233 ns 
tBHP-induced ROS, RFU 3242 ± 1606 3085 ± 2339 4471 ± 3927 ns 2909 ± 2345  .082 
PHZ-induced ROS, RFU 7633 ± 1324 8149 ± 1699 8215 ± 2621 ns 8527 ± 1623  .013 
Membrane-bound hemichromes, μΜ 25.9 ± 6.4 26.8 ± 6.7 30.2 ± 7.7  .061 22.6 ± 5.3  .074 
PS+ RBCs, % 0.86 ± 1.12 0.79 ± 1.00 0.69 ± 0.93 ns 0.23 ± 0.15  <.001 
Proteolytic proteasome activity 
CH-like, RFU 29 161 ± 13 451 29 690 ± 12915 31 618 ± 17 068 ns 28 526 ± 13 289 ns 
CASP-like, RFU 19 162 ± 8051 18 874 ± 4868 19 272 ± 6850 ns 19 172 ± 5 936 ns 
TR-like, RFU 48 420 ± 17 168 52 596 ± 18410 53 394 ± 18 781 ns 44 305 ± 12 097 ns 
CH-like, m, RFU 26 209 ± 22 747 25 423 ± 15 046 36 494 ± 25 101,  .003 44 142 ± 30 656  .004 
CASP-like, m, RFU 21 222 ± 19 234 22 757 ± 18 233 29 478 ± 19 267,  .007 35 463 ± 27 523  .011 
TR-like, m, RFU 27 755 ± 28 048 26 053 ± 21 901 31 217 ± 25 752 ns 29 430 ± 20 838 ns 
Plasma sEVs 
sEV concentration, ×1010/mL 20.2 ± 8.4 20.4 ± 9.5 21.2 ± 9.6 ns 7.4 ± 3.3  .004 
sEV size, nm 159 ± 24 152 ± 25 151 ± 28 .093 110 ± 14  <.001 
Plasma antioxidant capacity 
TAC, μM Fe2+ 406 ± 91 407 ± 87 381 ± 86,  .024 248 ± 54  <.001 
UAiAC, μM Fe2+ 217 ± 73 210 ± 72 207 ± 66 ns 124 ± 47  <.001 
UAdAC, μM Fe2+ 190 ± 60 197 ± 54 174 ± 67  .018 124 ± 32  <.001 

Before, after, week: repeated measures ANOVA or Friedman (Wilcoxon) tests; RBC units vs before: independent t test or Mann-Whitney U (2 samples) test.

CASP, caspase; CH, chymotrypsin; m; membrane; MCF, mean corpuscular fragility index; MFI, mechanical fragility index; ns, not significant; PHZ, phenylhydrazine; RFU, relative fluorescence units; ROS, reactive oxygen species; sEV, small EVs; TAC, total antioxidant capacity; tBHP, tert-butyl hydroperoxide; TR, trypsin; UAiAC, UA-independent antioxidant capacity; UAdAC, UA-dependent antioxidant capacity.

P < .05 vs before.

P < .05 vs after.

.05 < P < .10 (statistical trend).

or Create an Account

Close Modal
Close Modal